Related Experiment Videos
Severe hearing loss after liver transplantation
1Department of Gastroenterology, Hepatology, and Endocrinology, Medical School Hannover, Hannover, Germany. rifai.k@gmx.de
Transplantation Proceedings
|May 28, 2005
Summary
Severe hearing loss is common after liver transplantation, affecting 5% of patients. Early, bilateral hearing impairment suggests immunosuppressant toxicity, warranting further investigation into drug effects.
Area of Science:
- Otolaryngology
- Transplantation Medicine
- Pharmacology
Background:
- Hearing impairment post-organ transplantation is poorly understood.
- Limited data exists on hearing loss linked to immunosuppressive drugs.
Purpose of the Study:
- To assess the incidence and characteristics of severe hearing impairment in adult liver transplant recipients requiring hearing aids.
Main Methods:
- Retrospective analysis of 521 adult liver transplant patients.
- Identified 25 patients (5%) using hearing aids.
- Compared immunosuppressant use (tacrolimus, cyclosporine) with controls.
Main Results:
- 16 patients (64% of hearing aid users) developed severe hearing loss post-transplant.
- Onset was often early (within 2 years) and bilateral.
- Higher tacrolimus use noted in hearing loss patients compared to controls (P < .05).
- Tinnitus and sudden deafness were reported in some cases, with potential links to calcineurin inhibitors.
Conclusions:
- Liver transplant recipients have a high incidence of severe hearing loss.
- Early, bilateral onset suggests dose-dependent immunosuppressant toxicity.
- The role of specific immunosuppressants in hearing loss requires further evaluation.